.Specialties-07

Nephrology

Bone and Mineral Metabolism and Hyperkalemia Pre-register
Renal Anemia
Spherix Global Insights is hyper-focused on the renal market with studies of US nephrologists in active clinical practice. These two studies are currently fully enrolled. If you wish to pre-register for surveys in 2017, please click the button the right.

We invite nephrologists to share their experience and opinions. As always, we will share a few interesting results back with those who participate. Respondents remain anonymous and results are only reported in aggregate. Participation is on a first come basis.

.Specialties-10

Neurology

RealTime Dynamix Multiple Sclerosis – Quarterly

Spherix Global Insights is conducting independent market research on current dynamics and trends in multiple sclerosis (MS). In this  study, we will assess  treatment paradigms for the disease and identify the variables that are challenging them. These include new product entrants, generic penetration and risk benefit decision making. In particular, we would like to gather your feedback on the recent launch of generic glatimer acetate and treatment strategies for Lemtrada.

We invite neurologists to share their experience and opinions. As always, we will share a few interesting results back with those who participate. Respondents remain anonymous and results are only reported in aggregate.  Participation is on a first come basis.

Pre-register

.Specialties-08

Pulmonology

RealTime Dynamix Pulmonology – Quarterly

Spherix Global Insights will be conducting independent market research on current dynamics and trends in pulmonology. In this study, we will be collecting opinions on the new developments for the treatment of IPF, PAH, Cystic Fibrosis and other clinically complex respiratory diseases. .

We invite pulmonologists and critical care physicians working with patients with respiratory disease to share their experience and opinions in this study. As always, we will share a few interesting results back with those who participate. Participants remain anonymous and results are reported in aggregate. Participation is on a first come basis.

Pre-register

.Specialties-16

Rheumatology

Evolving Treatment Patterns in Rheumatoid Arthritis – Quarterly

Spherix Global Insights will be conducting independent market research on current dynamics and trends in rheumatology. In this survey, we will assess treatment paradigms for rheumatoid arthritis (RA) and psoriatic arthritis (PsA) and identify the variables that are challenging them. These include new product entrants, new delivery options for existing products, existing monitoring requirements and post marketing surveillance.

We invite US Rheumatologists to participate in our current survey about the evolving treatment patterns in Rheumatoid Arthritis and Psoriatic Arthritis. As always, we will share a few interesting results back with those who participate. Participants remain anonymous and results are reported in aggregate. Participation is on a first come basis.

Pre-register

.Specialties-13

Gastroenterology

Evolving Treatment Dynamics in IBD (UC/CD) – Quarterly

Spherix Global Insights will be conducting independent market research with US gastroenterologists about the evolving practice patterns for Inflammatory Bowel Disease. In this study, we will be exploring some key dynamics associated with the treatment of Ulcerative Colitis and Crohn’s Disease as well as your feedback on products in the pipeline.

We invite gastroenterologists to share their experience and opinions. As always, we will share a few interesting results back with those who participate. Respondents remain anonymous and results are only reported in aggregate. Participation is on a first come basis.

Pre-register

.Specialties-16

Dermatology

Evolving Practice Patterns in Psoriasis – Quarterly

Spherix Global Insights will be conducting independent market research with US Dermatologists about the evolving practice patterns for Psoriasis.
Each quarterly survey will be exploring some key dynamics associated with the treatment of Psoriasis as well as your feedback on products in the pipeline.

We invite Dermatologists to share their experience and opinions. As always, we will share a few interesting results back with those who participate. Respondents remain anonymous and results are only reported in aggregate. Participation is on a first come basis.

Pre-register